ArticleSchizophrenia bulletin2003
Overcoming barriers to research in early serious mental illness: issues for future collaboration.
Article in Schizophrenia bulletin, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Standardizing Fidelity to Evidence-Based Practice in the Early Psychosis Intervention Network.Psychiatric services (Washington, D.C.) · 2024Article
- A National Learning Health Experiment in Early Psychosis Research and Care.Psychiatric services (Washington, D.C.) · 2022Article
- Common Data Elements for National Institute of Mental Health-Funded Translational Early Psychosis Research.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2020Review
- Recruitment strategies for the detection of individuals at clinical high risk of developing psychosis.Epidemiology and psychiatric sciences · 2013Article
- A pathway to personalization of integrated treatment: informatics and decision science in psychiatric rehabilitation.Schizophrenia bulletin · 2011Article
- North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research.Schizophrenia bulletin · 2007Article
- Treating early psychosis: who, what, and when?Dialogues in clinical neuroscience · 2005Review
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Several methodological barriers impede discovery of early illness pathways in schizophrenia, including small samples, elongated study periods, and failure to integrate procedures and data across prodromal and first episode projects. A compounding factor is the tendency for single-site studies to focus narrowly on schizophrenia risk factors, rather than exploring vulnerability mechanisms that may cut across DSM-IV boundaries. To address these concerns, we discuss the merits of an integrated multisite approach to research that promotes large-scale investigation into the earliest phases of serious mental illness. The distinctive characteristics of this collaborative approach to early serious mental illness research could include (1) subject recruitment across several sites; (2) a broad diagnostic focus; (3) a core clinical and neuroscience assessment protocol; (4) longitudinal evaluation of subjects through a range of outcomes; and (5) an iterative approach to psychopathology research. This model represents a method for exploring prodromal phenotypes, for discovering causal risk mechanisms, and for investigating the biological and environmental interactions that define the early course of several disorders, including schizophrenia, bipolar illness, and borderline personality disorder. This strategy could speed discovery of clinical tools most relevant to the earliest stages of serious mental illness; i.e., better methods of screening, diagnosing, and treating mental disorders before symptoms and impairments solidify into chronic disabilities.
Indexed as
Identifiers
14989411What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.